BioSpace News Archive

Wilmington, Delaware, United States, Transparency Market Research Inc. - The rising threat of immunological and autoimmune diseases across the globe and the escalating awareness about ways to overcome these diseases may help the immunology drug market may gain substantial growth across the assessment period of 2020-2030

Wilmington, Delaware, United States, Transparency Market Research Inc. - The over-the-counter pain medication market is predicted to display notable growth over the forecast period from 2020 to 2030.

Wilmington, Delaware, United States, Transparency Market Research Inc. - Enormous studies have been made to guide home remedies and pharmacological interventions for natural cold, cough, and sore throat.

AMPAC Fine Chemicals, an SK pharmteco company, adds additional pharmaceutical development and engineering capabilities with the opening of a new Complex Molecule Chemistry & Engineering Center

MediGO , a Baltimore-based health care supply chain technology company, is helping transform the start of the organ donation and transplantation process with the launch of its new software solution known as Organ TeamLink.

Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company, today announced that it has been accepted to present a proffered talk at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference (CICON) being held in New York, NY from September 28 – October 1, 2022.

GNS, the leader in the use of “Digital Twins” and Causal AI & biosimulation technology for biopharmaceutical drug discovery and development, and Servier, a global pharmaceutical group, today announced a collaboration to advance drug discovery, translational, and clinical development efforts in Multiple Myeloma (MM).

Nine organizations are joining forces to present the second annual ILD Day on Wednesday, Sept. 14, to drive awareness of interstitial lung disease (ILD).

Rising Demand For Products To Treat Traumatic Brain Injuries, The Presence Of Key Players, Growing Research Activities, And Rising Investments By Key Players Driving The Market Growth In North America.

Brain Scientific (OTCQB:BRSF), a Florida-based medical device technology company, today announces receiving the Conformité Européenne (CE) Mark for the NeuroCap™.